Inviragen, Inc. is committed to developing life-saving vaccines to protect against emerging infectious diseases worldwide. These vaccines will take advantage of new trends in the global vaccine marketplace including:

• Economic growth of developing countries
• New global vaccine initiatives by non-profit organizations
• A growing public awareness of the value of vaccines for existing and emerging infectious diseases
• The need for vaccines as protection against potential bioweapon threats

Inviragen aims to bridge the gap between vaccine research and product development by creating a team of dedicated vaccine development specialists that will utilize global resources and capabilities to bring vaccine concepts to reality.